Huons Meditech Targets Latin American Market at 'Hospitalar 2026' Exhibition in Brazil
Huons Meditech Targets Latin American Market at 'Hospitalar 2026' Exhibition in Brazil
-Targeting Latin American market with ‘DermaShine Pro’-

▲Huons Meditech showcased at ‘Hospitalar 2026’ held in São Paulo, Brazil.
Huons Meditech strengthens its presence in the Latin American market by showcasing its flagship medical device lineup at ‘Hospitalar 2026’.
Huons Meditech (CEO Changwoo Ha) announced on May 22 that the company showcased its technological prowess and competitive edge at ‘Hospitalar 2026’, the largest medical device exhibition in Latin America, held from May 19 to 22 in São Paulo, Brazil.
The Hospitalar exhibition is a key event for medical device and healthcare professionals in the Latin American region, providing a significant platform for presenting the latest medical technologies and products.
At this year's exhibition, Huons Meditech showcased its flagship aesthetic medical device, the automatic drug injector 'DermaShine Pro', alongside its specialized multi-needles for skin boosters.
DermaShine Pro is an aesthetic medical device equipped with precise drug delivery function and a user-centric interface. The ‘Premium 9-Pin Needle’ is a dedicated sterile injection needle designed for use with both ‘DermaShine Pro’ and ‘DermaShine Balance’. Both products have successfully obtained European Medical Device Regulation (CE-MDR) certification.
DermaShine Pro received highly favorable reviews at the exhibition for successfully meeting the growing demands of the medical aesthetics market in Brazil and the wider Latin American market.
During the event, Huons Meditech focused on expanding its partnership network and discovering new business accounts through numerous strategic meetings with major local buyers. The company stated that these efforts have laid a solid foundation for strengthening its brand presence and market share across the region. "Moving forward, we will continue to participate in various international exhibitions to accelerate our global expansion." said Changwoo Ha, CEO of Huons Meditech.
Huons Meditech Wins DermaShine Trademark Case in China
Huons Meditech Expands into the Japanese Market with ‘Dermashine Duo_RF’
Huons Meditech Targets Southeast Asia Market at 'AMUSE 2026' in Indonesia
Huons Meditech Targets Latin American Market at 'Hospitalar 2026' Exhibition in Brazil
Huons Meditech Receives CE-MDR Approval for Aesthetic Drug Delivery System ‘Premium 9-Pin Needle’
Huons Meditech Strengthens Educational and Academic Marketing for Aesthetic Medical Device ‘Dermashine’
Humedix and Huons Meditech Sign Tripartite MOU with V&Co to Expand AI-powered Skin Diagnostics Business
Huons Meditech Showcased Innovative Medical Devices at ‘KIMES 2026’
Huons Group Chairman Yoon Sung-tae Attends in Inauguration of Endoscope Washer-Disinfector Production Line at India’s Vasu Group
Huons Meditech Showcases at ‘WHX Dubai 2026’
Huons Meditech Officially Launches ‘Dermashine Duo RF’, Combining Drug Delivery with Radiofrequency
Huons Meditech Participates in MEDICA 2025 in Germany